Discovery and Development of Antimalarial Drug- Resistance Reversal Agents
| dc.contributor.author | Andayi, Andrew W | |
| dc.date.accessioned | 2025-10-28T12:30:50Z | |
| dc.date.available | 2025-10-28T12:30:50Z | |
| dc.date.issued | 2023 | |
| dc.identifier.uri | http://repository.mut.ac.ke:8080/xmlui/handle/123456789/6740 | |
| dc.description.abstract | Despite the meritorious measures taken to curb the malaria scourge in the last two decades, the drug-resistance phenomenon threatens to reverse the gains made. Evidence of partial resistance against the first-line antimalarial drugs, the artemisininbased combination therapies, in Africa, a region that accounts for 95% of global malaria cases, has aroused fears that it could spread fast and significantly jeopardise malaria control and eradication efforts. While the antimalarial drug discovery pipeline has several, encouraging candidates emerging through it, unfortunately, the attrition rate is high, with some candidates failing either in preclinical studies or clinical trials. Moreover, the rate of emergence of drug-resistant Plasmodium parasite strains far exceeds that of the drug discovery and development process. These challenges demand novel strategies to complement the discovery and development of new therapeutics. One such strategy is the reversal of Plasmodium falciparum resistance to old antimalarials by combining these drugs with agents that specifically target drugresistance mechanisms. This strategy has been successfully used in the antibiotics field, with a classical successful example being the amoxicillin and clavulanic acid combination. In this chapter, we present a case for the need to discover and develop antimalarial drug-resistance reversal agents to prolong the efficacy and use of currently available antimalarial quinoline drugs as well as the re-use of old antimalarial quinoline drugs that have been rendered ineffective by drug-resistance. Furthermore, we provide an overview of noteworthy significant innovations that have been made in the field in search for antimalaria drug-resistance reversal agents. We conclude by providing perspectives on how these efforts can be expedited. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Bentham Science Publishers | en_US |
| dc.subject | 4-aminoquinoline, Chloroquine, Drug-resistance, Malaria, Plasmodium falciparum, P. falciparum chloroquine resistance transporter (PfCRT), Mefloquine, P. falciparum multidrug-resistance-1 (PfMDR1) transporter, Quinine, Quinolines, Resistance breakers, Resistance reversal agents. | en_US |
| dc.title | Discovery and Development of Antimalarial Drug- Resistance Reversal Agents | en_US |
| dc.type | Book chapter | en_US |
Files in this item
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Effect of Cell Composition on Internal Resistance on Open Circuit Voltage and Short Current Density of a Fabricated Titanium Dioxide Cell
(2018)This paper is a product of a research aimed at developing a solar energy powered titanium dioxide solar cell. The experimental design involved preparation of various ratios of titanium dioxide: graphite /iodine/KI mixtures ... -
Assessment of Factors Affecting the Implementation of Integrated Financial Management Information System in the County Governments: A Case Of Nyandarua County, Kenya
(2015-11)The study sought to assess factors affecting implementation of Integrated Financial Management Information System (IFMIS) in County Governments in Kenya. On focus was how staff resistance, and capacity and skills of IFMIS ... -
Prioritised identification of structural classes of natural products from higher plants in the expedition of antimalarial drug discovery
(Natural Products and Bioprospecting, 2023)The emergence and spread of drug-recalcitrant Plasmodium falciparum parasites threaten to reverse the gains made in the fight against malaria. Urgent measures need to be taken to curb this impending challenge. The ...
